Biopharmaceutical Analysis Firm (BRC), a Monterey, California-based group which holds a sound Drug Enforcement Administration (DEA) pharmaceutical hashish license, in Sequence A funding raised a complete of $20 million. Achari Ventures, Argonautic Ventures, AFI Capital Companions, Self Well being America, Delta Emerald Ventures, and several other distinguished non-public equities participated within the spherical, which Intrinsic Capital Companions spearheaded.